Cherry Bekaert

Cherry Bekaert is a large U.S. accounting, tax, assurance, and advisory firm rather than a biotech, pharma, or healthcare operating company. The firm serves clients across multiple industries, including a dedicated Healthcare & Life Sciences practice that supports healthcare providers and life sciences companies with audit, tax, CFO advisory, digital advisory, and related consulting services. Following a 2022 strategic investment from Parthenon Capital, the business operates through Cherry Bekaert LLP for attest services and Cherry Bekaert Advisory LLC for advisory and non-attest services. For a biotech analyst, Cherry Bekaert is best understood as a sector-focused professional services provider to life sciences companies, not a drug developer with an internal therapeutic pipeline.